Identifikatu
Taldeak
Ikertzaileak
Emaitzak
Edel del
Barco Morillo
Profesor Asociado CC. Salud
Francisco
García García
Hemen zaude
Lankidetzak
Francisco García García
Francisco García García-rekin lankidetzan egindako argitalpenak (2)
2022
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
Journal of Clinical Oncology, Vol. 71
2020
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation
Cancer Epidemiology, Vol. 67
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de